RIG‐I Mediated Neuron‐Specific IFN Type 1 Signaling in FUS‐ALS Induces Neurodegeneration and Offers New Biomarker‐Driven Individualized Treatment Options for (FUS‐)ALS

Marcel Naumann, Theresa M. Wierschin, Stefanie Kretschmer, Banaja P. Dash, Aaron Held, Andrea Salzinger, Kevin Peikert, Anže Karlek, Hannes Glaß, Dajana Großmann, René Günther, Susanne Petri, Annekathrin Rödiger, David Brenner, Francisco Pan‐Montojo, Eleonora Aronica, Markus Kipp, Vitaly Zimyanin, Jared Sterneckert, Torsten Grehl, Noah D. Seebacher, Tobias M. Böckers, Alberto Catanese, Brian J. Wainger, Patrick Oeckl, Min Ae Lee‐Kirsch, Andreas Hermann

Open source

DOI: 10.1002/advs.202417135
Published: 2026-01-28
Container: Advanced Science
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/advs.202417135,
  title = {RIG‐I Mediated Neuron‐Specific IFN Type 1 Signaling in FUS‐ALS Induces Neurodegeneration and Offers New Biomarker‐Driven Individualized Treatment Options for (FUS‐)ALS},
  author = {Marcel Naumann and Theresa M. Wierschin and Stefanie Kretschmer and Banaja P. Dash and Aaron Held and Andrea Salzinger and Kevin Peikert and Anže Karlek and Hannes Glaß and Dajana Großmann and René Günther and Susanne Petri and Annekathrin Rödiger and David Brenner and Francisco Pan‐Montojo and Eleonora Aronica and Markus Kipp and Vitaly Zimyanin and Jared Sterneckert and Torsten Grehl and Noah D. Seebacher and Tobias M. Böckers and Alberto Catanese and Brian J. Wainger and Patrick Oeckl and Min Ae Lee‐Kirsch and Andreas Hermann},
  year = {2026},
  journal = {Advanced Science},
  doi = {10.1002/advs.202417135},
  url = {https://doi.org/10.1002/advs.202417135}
}

RIS

TY  - JOUR
TI  - RIG‐I Mediated Neuron‐Specific IFN Type 1 Signaling in FUS‐ALS Induces Neurodegeneration and Offers New Biomarker‐Driven Individualized Treatment Options for (FUS‐)ALS
AU  - Marcel Naumann
AU  - Theresa M. Wierschin
AU  - Stefanie Kretschmer
AU  - Banaja P. Dash
AU  - Aaron Held
AU  - Andrea Salzinger
AU  - Kevin Peikert
AU  - Anže Karlek
AU  - Hannes Glaß
AU  - Dajana Großmann
AU  - René Günther
AU  - Susanne Petri
AU  - Annekathrin Rödiger
AU  - David Brenner
AU  - Francisco Pan‐Montojo
AU  - Eleonora Aronica
AU  - Markus Kipp
AU  - Vitaly Zimyanin
AU  - Jared Sterneckert
AU  - Torsten Grehl
AU  - Noah D. Seebacher
AU  - Tobias M. Böckers
AU  - Alberto Catanese
AU  - Brian J. Wainger
AU  - Patrick Oeckl
AU  - Min Ae Lee‐Kirsch
AU  - Andreas Hermann
PY  - 2026
JO  - Advanced Science
DO  - 10.1002/advs.202417135
UR  - https://doi.org/10.1002/advs.202417135
ER  -

APA

Naumann, M., Wierschin, T. M., Kretschmer, S., Dash, B. P., Held, A., Salzinger, A., Peikert, K., Karlek, A., Glaß, H., Großmann, D., Günther, R., Petri, S., Rödiger, A., Brenner, D., Pan‐Montojo, F., Aronica, E., Kipp, M., Zimyanin, V., Sterneckert, J., Grehl, T., Seebacher, N. D., Böckers, T. M., Catanese, A., Wainger, B. J., Oeckl, P., Lee‐Kirsch, M. A., & Hermann, A. (2026). RIG‐I Mediated Neuron‐Specific IFN Type 1 Signaling in FUS‐ALS Induces Neurodegeneration and Offers New Biomarker‐Driven Individualized Treatment Options for (FUS‐)ALS. Advanced Science. https://doi.org/10.1002/advs.202417135

Source records

crossref · retrieved 2026-09-26T16:10:45.296Z